The trial, sponsored by the University of Aarhus, aims to validate the use of Protac Ball BlanketsTM in treating insomnia associated with depression. If successful, this could position PBB as a viable alternative to pharmacological treatments, which often have side effects and risks of dependency. The market for insomnia treatments is substantial, with increasing demand for non-pharmacological options. The results could enhance the product's marketability and support its integration into clinical practice, potentially reducing healthcare costs associated with depression-related insomnia. Competitive analysis indicates a growing interest in non-drug therapies, suggesting a favorable environment for PBB's adoption if proven effective.